MN-001 showed statistically significant increases in HDL-C and HDL-P and significant early reduction in triglyceride, a reduction in body weight and a numerical improvement in liver fat ...

Cue Biopharma (NASDAQ:CUE) reported positive top-line results from a Phase II trial of CUE-221 in patients with moderate-to-severe chronic spontaneous urticaria, or CSU, whose disease was inadequately ...

Although not yet statistically significant, the difference in progression-free survival (PFS) outcomes continues to grow with ...

Preliminary results of an observational study being presented at the Annual Meeting of The European Association for the Study ...

A large Japanese real-world cohort study found that current heated tobacco product users had a higher risk of developing ...

Insmed Incorporated (NASDAQ:INSM) announced on September 21 that the FDA accepted its supplemental application for ARIKAYCE ...

The same medication is used for people with the same condition. The way they are compared is also the same.There is a ...

A new clinical trial suggests that a specific strain of probiotic bacteria may temporarily improve sleep quality and physical ...

Temple BrainFlow has shown a stronger correlation with cerebral blood volume than with changes in scalp blood volume. The ...

Low-dose radiation therapy may do more than relieve pain from early knee osteoarthritis, with a long-term analysis ...

CPI ranking can contribute to broader country-risk picture.IMF says corruption, governance weaknesses affect ...

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in ...